We are live on ! Find out more
WA

WPG Advisers Portfolio holdings

AUM $170M
1-Year Est. Return 33.45%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+33.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$129M
AUM Growth
+$10.4M
Cap. Flow
+$1.6M
Cap. Flow %
1.24%
Top 10 Hldgs %
40.33%
Holding
1,492
New
64
Increased
401
Reduced
442
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 12.58%
2 Financials 5.18%
3 Consumer Discretionary 5.17%
4 Communication Services 4.83%
5 Real Estate 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STT icon
151
State Street
STT
$50.7B
$106K 0.08%
910
-55
-6% -$6.14K
PFE icon
152
Pfizer
PFE
$153B
$103K 0.08%
4,052
+2,191
+118% +$54.1K
NVO
153
Novo Nordisk
NVO
$209B
$103K 0.08%
1,857
-228
-11% -$13.3K
BCI icon
154
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.96B
$103K 0.08%
4,767
+138
+3% +$2.9K
ISCB icon
155
iShares Morningstar Small-Cap ETF
ISCB
$292M
$103K 0.08%
1,616
MCD icon
156
McDonald's
MCD
$195B
$102K 0.08%
335
-45
-12% -$13.7K
UNM icon
157
Unum
UNM
$14.3B
$101K 0.08%
1,298
-31
-2% -$2.32K
VOYG
158
Voyager Technologies
VOYG
$2.54B
$101K 0.08%
3,389
+14
+0.4% +$484
PG icon
159
Procter & Gamble
PG
$339B
$100K 0.08%
654
+135
+26% +$21.1K
BNY
160
Bank of New York Mellon
BNY
$107B
$100K 0.08%
919
-21
-2% -$2.14K
MRSH
161
Marsh
MRSH
$91.5B
$100K 0.08%
496
-45
-8% -$9.26K
DOX icon
162
Amdocs
DOX
$6.22B
$99.6K 0.08%
1,214
+96
+9% +$8.32K
MDT icon
163
Medtronic
MDT
$112B
$99.5K 0.08%
1,045
-4
-0.4% -$368
UTHR icon
164
United Therapeutics
UTHR
$23.1B
$99.4K 0.08%
237
-19
-7% -$6.39K
FFIV icon
165
F5
FFIV
$22.7B
$99.2K 0.08%
307
-2
-0.6% -$626
DUK icon
166
Duke Energy
DUK
$97.3B
$98.1K 0.08%
793
-1
-0.1% -$121
GILD icon
167
Gilead Sciences
GILD
$165B
$97.1K 0.08%
875
-48
-5% -$5.46K
NOC icon
168
Northrop Grumman
NOC
$81.2B
$96.3K 0.07%
158
-68
-30% -$38.6K
SHW icon
169
Sherwin-Williams
SHW
$89.8B
$96.3K 0.07%
278
-4
-1% -$1.41K
GDDY icon
170
GoDaddy
GDDY
$11.5B
$95.9K 0.07%
701
-211
-23% -$32.5K
ABBV icon
171
AbbVie
ABBV
$435B
$95.9K 0.07%
414
+4
+1% +$815
NFJ
172
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.43B
$95.8K 0.07%
7,360
+175
+2% +$2.24K
VST icon
173
Vistra
VST
$47.4B
$94.8K 0.07%
484
-91
-16% -$18K
INCY icon
174
Incyte
INCY
$24.4B
$94.5K 0.07%
1,114
+45
+4% +$3.56K
MRK icon
175
Merck
MRK
$318B
$93K 0.07%
1,108
-15
-1% -$1.24K

Similar funds

WPG Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, WPG Advisers held 1,492 positions worth $129M, up 8.7% from $119M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

WPG Advisers's Q3 2025 filing shows 64 new, 401 increased, 442 reduced and 49 closed positions. Its largest new stake was Trex: 2,659 shares worth $137K. The largest sale was American Healthcare REIT, an estimated $2.47M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • WPG Advisers's largest Q3 2025 buy was Trex: 2,659 shares worth $137K.
  • WPG Advisers added most to First Trust RBA American Industrial Renaissance ETF in Q3 2025, an estimated $3.45M increase.
  • WPG Advisers's biggest Q3 2025 reduction was American Healthcare REIT, cutting an estimated $2.47M.
  • WPG Advisers fully exited Essex Property Trust in Q3 2025, selling an estimated $28.3K.
  • WPG Advisers's ten largest holdings make up 40% of its $129M portfolio in Q3 2025.
  • WPG Advisers opened 64 new positions and closed 49 in Q3 2025.
  • WPG Advisers's portfolio value rose 8.7% quarter-over-quarter to $129M.

Based on WPG Advisers's 13F filing for Q3 2025, filed 29 Oct 2025.